Finny logo
Finny logo
Dibs:
Dibs:
0

Qiagen (QGEN) earnings: expect 2% revenue growth

8:50 am ET, 06 May 2019

Qiagen N.V. (QGEN) is announcing earnings on May 06, after the market closes. Wondering what revenue and earnings will look like?

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $351M, which implies 2% growth rate year-over-year.

Earnings per share are expected to come in at $0.26.

How did the stock do last month?

Over the last month, Qiagen N.V. (QGEN) returned -3.86%.

What do analysts say about the stock?

Qiagen N.V. (QGEN) average analyst price target is 3.67% above its current price ($38.96).

For the latest price and information on Qiagen, please visit Finstead and ask for "QGEN", "QGEN analysis" or "QGEN news".

Powered by Froala Editor

Qiagen N.V. (QGEN) Stock Guide

Updated at: 11:50 am ET, 18 Sep 2020

Before we start: if you're looking for QGEN stock price, you can quickly find it out by visiting Finny and typing "QGEN quote". If you're looking for a quick scoop on QGEN stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "QGEN". You'll get all this info in one place. Or you can just type "QGEN news" to get the latest stock news.

Looking to buy or sell Qiagen N.V. (QGEN)? Interested in getting the full scoop on QGEN, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this QGEN stock guide, we'll address key questions about QGEN, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are QGEN earnings?
2. What is QGEN stock forecast (i.e., prediction)?
3. QGEN buy or sell? What is QGEN Finny Score?
4. What are the reasons to buy QGEN? Why should I buy QGEN stock?
5. What are the reasons to sell QGEN? Why should I sell QGEN stock?
6. What are QGEN key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are QGEN earnings?

QGEN trailing 12-month earnings per share (EPS) is $0.06.

Analyst Predictions

2. What is QGEN stock forecast (i.e., prediction)?

Based on QGEN analyst price targets, QGEN stock forecast is $52.64 (for a year from now). That means the average analyst price target for QGEN stock is $52.64. The prediction is based on 10 analyst estimates.

The low price target for QGEN is $32.00, while the high price target is $62.00.

QGEN analyst rating is Hold.

Analysis

3. QGEN buy or sell? What is QGEN Finny Score?

#{finnyScore:60}Our quantitative analysis shows 3 reasons to buy and 2 reasons to sell QGEN, resulting in Finny Score of 60.

4. What are the reasons to buy QGEN? Why should I buy QGEN stock?

Here are the reasons to buy QGEN stock:

  • Qiagen is one of the few companies to successfully launch FDA approved companion diagnostics, which should become a fast growing field over the near to medium term.
  • A growing installed base and menu expansion of Qiagen’s QIAsymphony platform should boost high-margin consumables sales and help improve customer switching costs.
  • Qiagen’s unique access to high-growth segments of the clinical diagnostics market and genome sequencing could make this company a takeover target.
  • QGEN quarterly revenue growth was 16.20%, higher than the industry and sector average revenue growth (1.20% and 0.83%, respectively). See QGEN revenue growth chart.
  • QGEN profitability is improving. The YoY profit margin change was 2.85 percentage points. See QGEN profitability chart.
  • QGEN cash to debt ratio is 0.44, higher than the average industry (0.21) and sector (0.16) cash to debt ratio. See QGEN cash to debt chart.

5. What are the reasons to sell QGEN? Why should I sell QGEN stock?

Let's look at the reasons to sell QGEN stock (i.e., the bear case):

  • Price and volume pressure in the HPV testing market will continue to slow Qiagen’s growth and shrink the company’s share of the molecular diagnostic market.
  • Although a fast-growing market, molecular diagnostics has numerous competitors with high risk for disruptive potential and new entrants.
  • Qiagen may never realize its ambitions in the genome sequencing market thanks to product development delays and strong advancements from competitors, in particular Illumina.
  • QGEN Price/Sales ratio is 7.20, which is high compared to its industry peers’ P/S ratios. See QGEN forward Price/Sales ratio chart.
  • QGEN Enterprise Value/Revenue multiple is 7.82, which is high compared to its industry peers’ Enterprise Value/Revenue multiples. See QGEN Enterprise Value/Revenue chart.

Key Stats

6. What are QGEN key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for QGEN:

Metrics QGEN
Price $50.10
Average Price Target / Upside $55.09 / 9.96%
Average Analyst Rating Hold
Forward Dividend Yield 0.00%
Industry Diagnostics & Research
Sector Healthcare
Number of Employees 4,952
Market Cap $11.97B
Forward P/E Ratio 21.64
Price/Book Ratio 7.43
Revenue (TTM) $1.61B
YoY Quarterly Revenue Growth 16.20%
Profit Margin 1.06%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us